Bio-Reference Laboratories (BRLI) Tops Q1 Views

March 3, 2011 8:44 AM EST
Bio-Reference Laboratories (NASDAQ: BRLI) reported Q1 EPS of $0.28, $0.11 better than the analyst estimate of $0.17. Revenue for the quarter came in at $121.66 million versus the consensus estimate of $119.12 million.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Add Your Comment